We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Late Angioplasty May Be Pointless

By HospiMedica staff writers
Posted on 14 Dec 2006
A new study suggests that angioplasty to open a blocked artery three to 28 days after a heart attack may be futile at best, and might even be harmful. More...


Researchers from New York University School of Medicine (NYU, NY, USA) and other academic institutions enrolled 2,166 people in 27 countries to receive either angioplasty three to 28 days after their heart attack and standard drug treatment--medicines to lower blood pressure and cholesterol, and aspirin and other anti-clotting drugs--or medicines alone. These were patients who had survived their original heart attack but had a single vessel completely blocked yet were stable because the heart was still receiving sufficient blood and oxygen from other vessels.

Four years later, 17% of those given angioplasty and drugs and nearly 16% of those given drugs alone had either died, suffered another heart attack, or developed heart failure, results considered to be statistically the same. There was an alarming trend toward more heart attacks in the angioplasty group (7% versus 5%) as time went on, although the researchers say this could have been a statistical fluke. The lack of benefit from angioplasty was not because the procedure did not work--it successfully reopened arteries more than 90% of the time. Instead, the findings suggested that once a blocked vessel had caused a heart attack, opening it was no better than taking standard medications for preventing future problems. The results of the study, led by Dr. Judith Hochman, cardiovascular research chief at NYU, were published in the December 7, 2006, issue of the New England Journal of Medicine.

"These findings were really a surprise,” said Dr. Elizabeth Nabel, director of the U.S. National Heart, Lung and Blood Institute (Bethesda, MD, USA). "For a long time we thought that opening up the artery any time after a heart attack was better than leaving it closed. My guess is you may see some guideline recommendations.”



Related Links:
New York University School of Medicine
U.S. National Heart, Lung and Blood Institute

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.